HUP0402139A3 - 17 alpha-hydroxy-14 betha-steroids with hormonal effect and their use for preparation of pharmaceutical compositions - Google Patents

17 alpha-hydroxy-14 betha-steroids with hormonal effect and their use for preparation of pharmaceutical compositions

Info

Publication number
HUP0402139A3
HUP0402139A3 HU0402139A HUP0402139A HUP0402139A3 HU P0402139 A3 HUP0402139 A3 HU P0402139A3 HU 0402139 A HU0402139 A HU 0402139A HU P0402139 A HUP0402139 A HU P0402139A HU P0402139 A3 HUP0402139 A3 HU P0402139A3
Authority
HU
Hungary
Prior art keywords
betha
steroids
alpha
hydroxy
preparation
Prior art date
Application number
HU0402139A
Other languages
English (en)
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0402139(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of HUP0402139A2 publication Critical patent/HUP0402139A2/hu
Publication of HUP0402139A3 publication Critical patent/HUP0402139A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0402139A 2001-09-12 2002-09-06 17 alpha-hydroxy-14 betha-steroids with hormonal effect and their use for preparation of pharmaceutical compositions HUP0402139A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12
PCT/EP2002/010041 WO2003022864A1 (en) 2001-09-12 2002-09-06 17alpha-hydroxy-14beta-steroids with hormonal effect

Publications (2)

Publication Number Publication Date
HUP0402139A2 HUP0402139A2 (hu) 2005-02-28
HUP0402139A3 true HUP0402139A3 (en) 2012-12-28

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402139A HUP0402139A3 (en) 2001-09-12 2002-09-06 17 alpha-hydroxy-14 betha-steroids with hormonal effect and their use for preparation of pharmaceutical compositions

Country Status (29)

Country Link
US (1) US7169769B2 (hu)
EP (1) EP1427748B1 (hu)
JP (1) JP4471653B2 (hu)
KR (1) KR100940054B1 (hu)
CN (1) CN1257913C (hu)
AR (1) AR036462A1 (hu)
AT (1) ATE395352T1 (hu)
AU (1) AU2002339536B2 (hu)
BR (1) BR0212409A (hu)
CA (1) CA2505575C (hu)
CY (1) CY1108152T1 (hu)
DE (1) DE60226623D1 (hu)
DK (1) DK1427748T3 (hu)
EC (1) ECSP045012A (hu)
ES (1) ES2305306T3 (hu)
HK (1) HK1063637A1 (hu)
HR (1) HRP20040193A2 (hu)
HU (1) HUP0402139A3 (hu)
IL (2) IL160451A0 (hu)
IS (1) IS2555B (hu)
MX (1) MXPA04002418A (hu)
NO (1) NO326624B1 (hu)
NZ (1) NZ531487A (hu)
PL (1) PL207493B1 (hu)
PT (1) PT1427748E (hu)
RU (1) RU2294332C2 (hu)
TW (1) TWI221154B (hu)
WO (1) WO2003022864A1 (hu)
ZA (1) ZA200401992B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
WO2000053619A1 (en) * 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
US6905714B2 (en) * 2000-02-29 2005-06-14 National University Of Singapore Method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
EP1427748A1 (en) 2004-06-16
AR036462A1 (es) 2004-09-08
NO20041010L (no) 2004-03-10
HK1063637A1 (en) 2005-01-07
NZ531487A (en) 2005-08-26
PL207493B1 (pl) 2010-12-31
ATE395352T1 (de) 2008-05-15
CA2505575C (en) 2010-01-26
MXPA04002418A (es) 2004-07-30
WO2003022864A1 (en) 2003-03-20
RU2294332C2 (ru) 2007-02-27
ZA200401992B (en) 2005-04-21
CN1553917A (zh) 2004-12-08
DK1427748T3 (da) 2008-09-08
IL160451A (en) 2009-11-18
ES2305306T3 (es) 2008-11-01
RU2004110934A (ru) 2005-08-20
KR100940054B1 (ko) 2010-02-04
IL160451A0 (en) 2004-07-25
IS2555B (is) 2009-10-15
EP1427748B1 (en) 2008-05-14
PL368727A1 (en) 2005-04-04
JP2005505566A (ja) 2005-02-24
CA2505575A1 (en) 2003-03-20
NO326624B1 (no) 2009-01-19
CY1108152T1 (el) 2014-02-12
KR20040039346A (ko) 2004-05-10
JP4471653B2 (ja) 2010-06-02
US20040259849A1 (en) 2004-12-23
US7169769B2 (en) 2007-01-30
BR0212409A (pt) 2004-08-03
HRP20040193A2 (en) 2004-08-31
IS7165A (is) 2004-02-26
AU2002339536B2 (en) 2008-04-24
ECSP045012A (es) 2004-09-27
DE60226623D1 (de) 2008-06-26
TWI221154B (en) 2004-09-21
HUP0402139A2 (hu) 2005-02-28
PT1427748E (pt) 2008-08-27
CN1257913C (zh) 2006-05-31

Similar Documents

Publication Publication Date Title
HUP0402497A3 (en) Pharmaceutical compositions containing two activ ingredients and their uses
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
HUP0401984A3 (en) Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
HUP0400052A3 (en) Carboxamide-substituted phenylurea derivatives and pharmaceutical compositions containing them and their use
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
HUP0103874A3 (en) Use of antibiotics and pharmaceutical compositions comprising thereof
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HU9901570D0 (en) Use of nanodispersions in pharmaceutical compositions
HU0103558D0 (en) Pharmaceutical composition for the treatment of stroke and traumatic brain insury
HUP0201834A3 (en) Use of thyromimetic compounds for the manufacture of a pharmaceutical composition for the treatment of hair loss and such compositions
HUP0202862A3 (en) Pharmaceutical composition containing novel combination of loteprednol and antihistamines
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
GB0108470D0 (en) Pharmaceutical compositions and their use
SI1411921T2 (sl) Farmacevtski sestavki, ki vsebujejo terbinafin, in njihova uporaba
HUP0400386A3 (en) Tablet comprising cetirizine and pseudoephedrine and its use for preparation of pharmaceutical compositions
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
HUP0301317A3 (en) Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
IL153487A0 (en) Pharmaceutical compositions and methods for use
IL153897A0 (en) Pharmaceutical compositions and methods for use
IL157451A0 (en) Medicinal compositions comprising diclofenac and ornoprostil
HUP0202753A3 (en) Pharmaceutical compositions containing novel combination of loteprednol and b2-adrenoceptor agonists and their use
HUP0402139A3 (en) 17 alpha-hydroxy-14 betha-steroids with hormonal effect and their use for preparation of pharmaceutical compositions

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: N.V. ORGANON, NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

FD9A Lapse of provisional protection due to non-payment of fees